Photobiomodulation Therapy for Alveolar Osteitis Recovery in Oral Contraceptive Users
DOI:
https://doi.org/10.64149/J.Carcinog.24.3.237-246Keywords:
Alveolar osteitis, Oral contraceptives, laser therapy, Zinc oxide eugenol.Abstract
Background: Users of oral contraceptives have an elevated possibility of alveolar osteitis (dry socket) after extraction of tooth because of impaired fibrinolytic activity."
Objective: This randomized clinical trial aimed to assess the efficacy of low-level laser therapy (photobiomodulation) combined with zinc oxide eugenol (ZOE) dressing in managing alveolar osteitis (AO) among women using oral contraceptives (OCs).
Methods: Fifty female cases diagnosed with dry socket following traumatic lower molar extraction have been randomly assigned to either an experimental group (laser + ZOE) or a control group (ZOE only). Pain levels, Oral Health-Related Quality of Life (OHIP-5), and socket volume have been measured at multiple intervals over 30 days.
Results: The results revealed a significantly greater reduction in pain scores and socket volume, as well as improved OHIP-5 scores in the laser group, particularly from day 4 onward. Conclusion: These findings suggest that laser therapy shows potential adjunct to conventional treatment in controlling pain and enhancing healing outcomes in oral contraceptive users,
